title: Long-term culture of human urothelial cells--a qualitative analysis.
abstract: Today, in vitro culturing of autologous cells is an established method in the field of tissue reconstruction. It can be applied to urothelial cells and could have many clinical implications in urological reconstructive surgery. This development calls for quality controls concerning cells used for clinical treatment when cells are autotransplanted back to the patient. We have studied cultured cells in order to detect whether genetic or morphologic changes occur. Urothelial cells isolated from bladder lavage were cultured according to different protocols based on the presence or absence of feeder cells. Genetic studies were performed by means of karyotyping with standard G-banding and interphase fluorescent in situ hybridization (FISH) analyses. The morphology of these epithelial cells was judged as well as immunostaining for epithelial cell markers. In addition, to minimize the risk of feeder cell contamination, proliferation studies were performed on cultures including feeder cells that had been pretreated with different doses of mitomycin or radiation. In initial studies, when using feeder cells in each passage according to standard protocols, urothelial cells proliferated unfavourably after the fourth passage with increasing numbers of mouse cells as well as urothelial tetraploid cells. We could also show that urothelial cells from bladder lavage need feeder cells in order to establish primary cultures. Further propagation up to 14 passages was performed without feeder cells and the urothelial cells retained normal karyotypes. We also found that mitomycin treatment had its main effect on feeder cells during the first 2 h. When feeder cells were irradiated, 20 Gy was effective and no feeder cell contamination was seen. In conclusion, we found that a high standard of quality in urothelial cell culturing can be achieved with a careful culturing technique.
authors.affiliation: Department of Molecular Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden. magdalena.fossum@kbh.ki.se
authors.forename: Magdalena
authors.initials: M
authors.lastname: Fossum
authors.forename: Fredrik
authors.initials: F
authors.lastname: Lundberg
authors.forename: Kerstin
authors.initials: K
authors.lastname: Holmberg
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Schoumans
authors.forename: Gunnar
authors.initials: G
authors.lastname: Kratz
authors.forename: Agneta
authors.initials: A
authors.lastname: Nordenskjöld
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D003584:Cytological Techniques / Q000379:methods; D006801:Humans; D007150:Immunohistochemistry; D007621:Karyotyping; D051379:Mice; D016685:Mitomycin / Q000008:administration & dosage; D041701:Swiss 3T3 Cells; D013997:Time Factors; D019459:Urothelium / Q000166:cytology* / Q000187:drug effects / Q000528:radiation effects / Q000648:ultrastructure
chemical_list: D016685:Mitomycin